Editorial: Angiogenesis and Angiogenesis Inhibitors in Oral Cancer

Abdelhakim Salem; Elin Hadler-Olsen; Ahmed Al-Samadi

doi:10.3389/froh.2021.816963

Editorial: Angiogenesis and Angiogenesis Inhibitors in Oral Cancer

Front Oral Health. 2021 Dec 15:2:816963. doi: 10.3389/froh.2021.816963. eCollection 2021.

Authors

Abdelhakim Salem^{1

2}, Elin Hadler-Olsen^{3

4}, Ahmed Al-Samadi^{1

2}

Affiliations

¹ Department of Oral and Maxillofacial Diseases, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
² Translational Immunology Research Program (TRIMM), Research Program Unit (RPU), University of Helsinki, Helsinki, Finland.
³ Department of Medical Biology, Faculty of Health Sciences, UiT the Arctic University of Norway, Tromsø, Norway.
⁴ The Public Dental Health Service Competence Center of Northern Norway, Tromsø, Norway.

No abstract available

Keywords: angiogenesis; angiogenesis inhibitor; head and neck squamous cell carcinoma (HNSCC); oral cancer (OC); oral squamous cell carcinoma; salivary duct carcinoma (SDC); vasculogenic mimicry (VM).

Publication types

Editorial